APOA1 and neoplasm: Furthermore, Emmanuel Scotet et al. identified two different lipid-related ligands of Vɣ9Vδ2 TCR in tumor cells, namely apolipoprotein A1 (Apo-A1) and ATP synthase/F1-ATPase (high-affinity apo A-I receptor).